Nanotechnology - Your Online Guide

Nanotechnology Advisory Group - latest meeting update 

What is the Nanotechnology Advisory Group?

The NICNAS Nanotechnology Advisory Group (NAG) has the objective to advise the Director on strategic approaches to address regulatory and safety impacts of industrial nanomaterials. The NAG has members drawn from industry, community, academia and NICNAS. The NAG was convened following consultation with the Community Engagement Forum (CEF) and Industry Government Consultative Committee (IGCC).


For detailed Terms of Reference and mode of action, please click here.


For further information please contact the Committee Secretariat NAG@nicnas.gov.au or 02 8577 8800. 

Who is the Nanotechnology Advisory Group?

Committee Chair
Dr Roshini Jayewardene (NICNAS)

Committee Secretariat
Dr Trang Pham (NICNAS)



  • Mr Leo Hyde, R&D Manager Australia/Asean, DuPont (Australia) Ltd (IGCC nominee via the Australian Paint Manufacturers Federation)

  • Mr Craig Brock, Director, Policy & Public Affairs, ACCORD (IGCC nominee via ACCORD)

  • Mr Geoff MacAlpine, Director, Industry Development, PACIA (IGCC nominee via PACIA


  • Dr Bro Sheffield-Brotherton, Scientific Advisor, National Toxics Network (CEF member – environmental interests)

  • Ms Renata Musolino, OHS Information Officer, Victorian Trades Hall Council (CEF member – OHS interests)

  • Prof Chris Winder, Chemical Safety and Applied Toxicology, UNSW (ex-CEF – public health interests


  • Prof Brian Priestly, Director, Australian Centre for Human Health Risk Assessment, Department of Epidemiology & Preventive Medicine, Monash University

  • Prof Colin Raston, Director, Centre for Strategic Nano-Fabrication

NICNAS Representative:
Dr Matthew Gredley (NICNAS)

How will the Nanotechnology Advisory Group operate?

Terms of Reference
In light of the current state of knowledge on the health, safety and environmental impacts of nanomaterials, the Advisory Group will:


  1. consider the implications of the potential impact of nanomaterials on public health, workers and the environment;

  2. consider the implications of nanomaterials for the regulation of industrial chemicals in Australia; and

  3. advise the Director on measures that NICNAS can take to address these implications.

Modus operandi

It is expected that the Advisory Group will:

  • Convene in face-to-face meetings two times per year; additional meetings (including teleconferences) will be called if suitably justified;

  • Complete out-of-session work (as needed) by the stated deadline; NICNAS to provide work at least 10 working days to complete work; NICNAS to provide an estimate of time (hours) required to complete the work;

  • Receive updates from NICNAS on the health, safety and environmental impacts of nanomaterials (including actions arising from National Government Agencies, International events, and research and development) to assist with the formulation of advice;

  • Provide NICNAS with updates from their sectors on the health, safety and environmental impacts of nanomaterials to assist with the formulation of advice;

  • Share information (document) via an extra-net;

  • Call on additional experts for technical input as required;

  • Liaise with other NICNAS advisory groups as appropriate; and

  • Operate in accordance with the principles of the NICNAS Community Engagement Charter.

<< Back to Nanotechnology Guide Index  |  On to next topic  >>